ロード中...

Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice

Non-antivitamin K oral anticoagulants (NOACs) have recently emerged as a new class of antithrombotic drugs. Four large-scale, randomised controlled trials (RCT) accredited dabigatran, rivaroxaban and edoxaban with evident advantages for stroke prevention in atrial fibrillation (AF) compared with war...

詳細記述

保存先:
書誌詳細
出版年:Eur Cardiol
主要な著者: Dan, Gheorghe-Andrei, Buzea, Adrian Catalin
フォーマット: Artigo
言語:Inglês
出版事項: Radcliffe Cardiology 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6159476/
https://ncbi.nlm.nih.gov/pubmed/30310429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2015.10.2.76
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!